相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Immunological challenges for peptide-based immunotherapy in glioblastoma
Malte Mohme et al.
CANCER TREATMENT REVIEWS (2014)
EGFRvIII mCAR-Modified T-Cell Therapy Cures Mice with Established Intracerebral Glioma and Generates Host Immunity against Tumor-Antigen Loss
John H. Sampson et al.
CLINICAL CANCER RESEARCH (2014)
Mouse glioma immunotherapy mediated by A2B5+GL261 cell lysate-pulsed dendritic cells
Ming Xu et al.
JOURNAL OF NEURO-ONCOLOGY (2014)
Gliomas Promote Immunosuppression through Induction of B7-H1 Expression in Tumor-Associated Macrophages
Orin Bloch et al.
CLINICAL CANCER RESEARCH (2013)
An update on vaccine therapy and other immunotherapeutic approaches for glioblastoma
David A. Reardon et al.
EXPERT REVIEW OF VACCINES (2013)
Access to the Nucleus and Functional Association with c-Myc Is Required for the Full Oncogenic Potential of ΔEGFR/EGFRvIII
Anupama E. Gururaj et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Cell-based Immunotherapy Against Gliomas: From Bench to Bedside
M. Sarah S. Bovenberg et al.
MOLECULAR THERAPY (2013)
Stem-like Tumor-Initiating Cells Isolated from IL13Rα2 Expressing Gliomas Are Targeted and Killed by IL13-Zetakine-Redirected T Cells
Christine E. Brown et al.
CLINICAL CANCER RESEARCH (2012)
The Spectrum of Vaccine Therapies for Patients With Glioblastoma Multiforme
Laura K. Aguilar et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2012)
Recognition of Glioma Stem Cells by Genetically Modified T Cells Targeting EGFRvIII and Development of Adoptive Cell Therapy for Glioma
Richard A. Morgan et al.
HUMAN GENE THERAPY (2012)
Preclinical Evaluation of a Genetically Engineered Herpes Simplex Virus Expressing Interleukin-12
James M. Markert et al.
JOURNAL OF VIROLOGY (2012)
Soluble factors secreted by glioblastoma cell lines facilitate recruitment, survival, and expansion of regulatory T cells: implications for immunotherapy
Courtney A. Crane et al.
NEURO-ONCOLOGY (2012)
Insights gained from modelling high-grade glioma in the mouse
S. L. Rankin et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2012)
Experimental immunotherapy for malignant glioma: lessons from two decades of research in the GL261 model
Wim Maes et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
The Antisense Oligonucleotide Trabedersen (AP 12009) for the Targeted Inhibition of TGF-β2
Frank Jaschinski et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2011)
Genetic Modeling of Gliomas in Mice: New Tools to Tackle Old Problems
Dolores Hambardzumyan et al.
GLIA (2011)
Cancer Immunotherapy Comes of Age
Suzanne L. Topalian et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Immunotherapy coming of age: What will it take to make it standard of care for glioblastoma?
Amy B. Heimberger et al.
NEURO-ONCOLOGY (2011)
Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
Robert D. Schreiber et al.
SCIENCE (2011)
Retrovirally engineered T-cell-based immunotherapy targeting type III variant epidermal growth factor receptor, a glioma-associated antigen
Masasuke Ohno et al.
CANCER SCIENCE (2010)
Glioblastoma cancer stem cells: heterogeneity, microenvironment and related therapeutic strategies
Tetyana Denysenko et al.
CELL BIOCHEMISTRY AND FUNCTION (2010)
Immunological Factors Relating to the Antitumor Effect of Temozolomide Chemoimmunotherapy in a Murine Glioma Model
Tai-Gyu Kim et al.
CLINICAL AND VACCINE IMMUNOLOGY (2010)
HER2-Specific T Cells Target Primary Glioblastoma Stem Cells and Induce Regression of Autologous Experimental Tumors
Nabil Ahmed et al.
CLINICAL CANCER RESEARCH (2010)
被撤回的出版物: Glioma-Associated Cancer-Initiating Cells Induce Immunosuppression (Retracted article. See vol. 21, pg. 2189, 2015)
Jun Wei et al.
CLINICAL CANCER RESEARCH (2010)
Implications for immunotherapy of tumor-mediated T-cell apoptosis associated with loss of the tumor suppressor PTEN in glioblastoma
James S. Waldron et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2010)
A novel pre-clinical in vivo mouse model for malignant brain tumor growth and invasion
Laura M. Shelton et al.
JOURNAL OF NEURO-ONCOLOGY (2010)
Soluble CD70: a novel immunotherapeutic agent for experimental glioblastoma Laboratory investigation
James Miller et al.
JOURNAL OF NEUROSURGERY (2010)
Normal human monocytes exposed to glioma cells acquire myeloid-derived suppressor cell-like properties
Jennifer C. Rodrigues et al.
NEURO-ONCOLOGY (2010)
Mesenchymal Stem Cells Modified with a Single-Chain Antibody against EGFRvIII Successfully Inhibit the Growth of Human Xenograft Malignant Glioma
Irina V. Balyasnikova et al.
PLOS ONE (2010)
Genetically Engineered Mouse Models of Brain Cancer and the Promise of Preclinical Testing
Jason T. Huse et al.
BRAIN PATHOLOGY (2009)
Isolation and characterization of cancer stem like cells in human glioblastoma cell lines
Lei Qiang et al.
CANCER LETTERS (2009)
Systemic Inhibition of Transforming Growth Factor-β in Glioma-Bearing Mice Improves the Therapeutic Efficacy of Glioma-Associated Antigen Peptide Vaccines
Ryo Ueda et al.
CLINICAL CANCER RESEARCH (2009)
Honokiol-mediated Inhibition of PI3K/mTOR Pathway A Potential Strategy to Overcome Immunoresistance in Glioma, Breast, and Prostate Carcinoma Without Impacting T Cell Function
Courtney Crane et al.
JOURNAL OF IMMUNOTHERAPY (2009)
Expression of HMP/AN2, a melanoma associated antigen, in murine cerebral gliomas: potential for radioimmunotargeting
Asit K. Paul et al.
JOURNAL OF NEURO-ONCOLOGY (2009)
Rat brain tumor models in experimental neuro-oncology: the C6, 9L, T9, RG2, F98, BT4C, RT-2 and CNS-1 gliomas
Rolf F. Barth et al.
JOURNAL OF NEURO-ONCOLOGY (2009)
Immunological considerations of modern animal models of malignant primary brain tumors
Michael E. Sughrue et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2009)
An epidermal growth factor receptor variant III-targeted vaccine is safe and immunogenic in patients with glioblastoma multiforme
John H. Sampson et al.
MOLECULAR CANCER THERAPEUTICS (2009)
DC vaccination with anti-CD25 treatment leads to long-term immunity against experimental glioma
Wim Maes et al.
NEURO-ONCOLOGY (2009)
Improved therapeutic efficacy using vaccination with glioma lysate-pulsed dendritic cells combined with IP-10 in murine glioma
Xiao-bing Jiang et al.
VACCINE (2009)
CD133/prominin-1 is a potential therapeutic target for antibody-drug conjugates in hepatocellular and gastric cancers
L. M. Smith et al.
BRITISH JOURNAL OF CANCER (2008)
Akt-Dependent Proapoptotic Effects of Dietary Restriction on Late-Stage Management of a Phosphatase and Tensin Homologue/Tuberous Sclerosis Complex 2-Deficient Mouse Astrocytoma
Jeremy Marsh et al.
CLINICAL CANCER RESEARCH (2008)
Postoperative adjuvant dendritic cell-based immunotherapy in patients with relapsed glioblastoma multiforme
Steven De Vleeschouwer et al.
CLINICAL CANCER RESEARCH (2008)
Stem cell marker CD133 affects clinical outcome in glioma patients
Felix Zeppernick et al.
CLINICAL CANCER RESEARCH (2008)
Phase II randomized controlled trial of an epidermal growth factor vaccine in advanced non-small-cell lung cancer
Elia Neninger Vinageras et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
A phase I trial of Ad•hIFN-β gene therapy for glioma
E. Antonio Chiocca et al.
MOLECULAR THERAPY (2008)
Identification of cells initiating human melanomas
Tobias Schatton et al.
NATURE (2008)
Treg Depletion Inhibits Efficacy of Cancer Immunotherapy: Implications for Clinical Trials
James F. Curtin et al.
PLOS ONE (2008)
Tumor-specific immunotherapy targeting the EGFRvIII mutation in patients with malignant glioma
John H. Sampson et al.
SEMINARS IN IMMUNOLOGY (2008)
Persistence of CD133+ cells in human and mouse glioma cell lines:: detailed characterization of GL261 glioma cells with cancer stem cell-like properties
Anhua Wu et al.
STEM CELLS AND DEVELOPMENT (2008)
Intracranial glioblastoma models in preclinical neuro-oncology: neuropathological characterization and tumor progression
Marianela Candolfi et al.
JOURNAL OF NEURO-ONCOLOGY (2007)
Cross-priming by temozolomide enhances antitumor immunity of dendritic cell vaccination in murine brain tumor model
Sung-Dong Park et al.
VACCINE (2007)
Prolonged survival of mice with established intracerebral glioma receiving combined treatment with peroxisome proliferator-activated receptor-γ thiazolidinedione agonists and interleukin-2-secreting syngeneic/allogeneic fibroblasts
Alessandra Spagnolo et al.
JOURNAL OF NEUROSURGERY (2007)
Daoy medulloblastoma cells that express CD133 are radioresistant relative to CD133- cells, and the CD133+ sector is enlarged by hypoxia
Ed R. Blazek et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2007)
Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma
Andrew T. Parsa et al.
NATURE MEDICINE (2007)
Systemic CTLA-4 blockade ameliorates glioma-induced changes to the CD4(+) T cell compartment without affecting regulatory T-cell function
Peter E. Fecci et al.
CLINICAL CANCER RESEARCH (2007)
Inhibition of TGF-beta 2 with AP 12009 in recurrent malignant gliomas: From preclinical to phase I/II studies
Peter Hau et al.
OLIGONUCLEOTIDES (2007)
Expression of MHC I and NK ligands on human CD133(+) glioma cells: possible targets of immunotherapy
Anhua Wu et al.
JOURNAL OF NEURO-ONCOLOGY (2007)
Antitumor effects of a xenogeneic survivin bone marrow derived dendritic cell vaccine against murine GL261 gliomas
Michael J. Ciesielski et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2006)
Neurospheres enriched in cancer stem-like cells are highly effective in eliciting a dendritic cell-mediated immune response against malignant gliomas
Serena Pellegatta et al.
CANCER RESEARCH (2006)
Enhancement of anti-tumor immunity specific to murine glioma by vaccination with tumor cell lysate-pulsed dendritic cells engineered to produce interleukin-12
Chang-Hyun Kim et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2006)
Requirement for CD44 in homing and engraftment of BCR-ABL-expressing leukemic stem cells
Daniela S. Krause et al.
NATURE MEDICINE (2006)
Targeting of CD44 eradicates human acute myeloid leukemic stem cells
Liqing Jin et al.
NATURE MEDICINE (2006)
Gene-linked shift in ganglioside distribution influences growth and vascularity in a mouse astrocytoma
Laura E. Abate et al.
JOURNAL OF NEUROCHEMISTRY (2006)
Dendritic cells pulsed with glioma lysates induce immunity against syngeneic intracranial gliomas and increase survival of tumor-bearing mice
S. Pellegatta et al.
NEUROLOGICAL RESEARCH (2006)
Chemotherapy resistance of glioblastoma stem cells
A. Eramo et al.
CELL DEATH AND DIFFERENTIATION (2006)
Detailed characterization of the mouse glioma 261 tumor model for experimental glioblastoma therapy
Tunde Szatmari et al.
CANCER SCIENCE (2006)
Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines
Jeongwu Lee et al.
CANCER CELL (2006)
Identification of a glioma antigen, GARC-1, using cytotoxic T lymphocytes induced by HSV cancer vaccine
Y Iizuka et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Delivery of dendritic cells engineered to secrete IFN-α into central nervous system tumors enhances the efficacy of peripheral tumor cell vaccines:: Dependence on apoptotic pathways
N Kuwashima et al.
JOURNAL OF IMMUNOLOGY (2005)
Increased efficacy of an interleukin-12-secreting herpes simplex virus in a syngeneic intracranial murine glioma model
EK Hellums et al.
NEURO-ONCOLOGY (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Downregulation of major histocompatibility complex antigens in invading glioma cells: stealth invasion of the brain
D Zagzag et al.
LABORATORY INVESTIGATION (2005)
Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-β signals in vivoi
ML Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
PI3K/Akt signalling pathway and cancer
JAF Vara et al.
CANCER TREATMENT REVIEWS (2004)
Growth inhibition of an orthotopic glioblastoma in immunocompetent mice by cationic lipid-DNA complexes
RJ Higgins et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2004)
Vaccination with tumor cell lysate-pulsed dendritic cells augments the effect of IFN-β gene therapy for malignant glioma in an experimental mouse intracranial glioma
R Saito et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Antiangiogenic and proapoptotic effects of dietary restriction on experimental mouse and human brain tumors
P Mukherjee et al.
CLINICAL CANCER RESEARCH (2004)
Isolation of cancer stem cells from adult glioblastoma multiforme
XP Yuan et al.
ONCOGENE (2004)
Spontaneous regression of experimental gliomas - an immunohistochemical and MRI study of the C6 glioma spheroid implantation model
GH Vince et al.
EXPERIMENTAL NEUROLOGY (2004)
Identification of human brain tumour initiating cells
SK Singh et al.
NATURE (2004)
Sequential delivery of interferon-α gene and DCs to intracranial gliomas promotes an effective antitumor response
T Tsugawa et al.
GENE THERAPY (2004)
SD-208, a novel transforming growth factor β receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo
M Uhl et al.
CANCER RESEARCH (2004)
TGF-β signaling in tumor suppression and cancer progression
R Derynck et al.
NATURE GENETICS (2001)
Genetically engineered mouse models of astrocytoma: GEMs in the rough?
KM Reilly et al.
SEMINARS IN CANCER BIOLOGY (2001)
Immunization with dendritic cells pulsed with tumor extract increases survival of mice bearing intracranial gliomas
HT Ni et al.
JOURNAL OF NEURO-ONCOLOGY (2001)
Vascular apoptosis and involution in gliomas precede neovascularization: A novel concept for glioma growth and angiogenesis
D Zagzag et al.
LABORATORY INVESTIGATION (2000)
分享论文
